Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Veterinary Compounding for Myasthenia Gravis

Author(s):  Davidson Gigi S

Issue:  Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Page(s):  398-401

Veterinary Compounding for Myasthenia Gravis Page 1
Veterinary Compounding for Myasthenia Gravis Page 2
Veterinary Compounding for Myasthenia Gravis Page 3
Veterinary Compounding for Myasthenia Gravis Page 4

Download in electronic PDF format for $75

Abstract:  Myasthenia gravis is a neuromuscular disease commonly encountered in veterinary medicine. With accurate diagnosis, treatment, and compliant caregivers, the prognosis for remission and a normal life is good. Unfortunately, drugs used to diagnose and treat myasthenia gravis are frequently unavailable due to manufacturer shortages. During these periods, compounding pharmacists can play a valuable role in maintaining a good quality of life for these patients by providing compounded versions of drugs that are commercially unavailable.

Related Keywords: formulations, myasthenia gravis, muscle disorders, dogs, veterinary medicine, muscle weakness, cats, edrophomium hydrochloride, acetylcholinesterase inhibitor, acetycholine, neurotransmitter, anticholinesterase agents, pyridostigmine bromide, cellulose, methylcellulose, excipients

Related Categories: EXCIPIENTS, FORMULATIONS, VETERINARY, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
Sep/Oct 2008
Pg. 398-401

The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
Mar/Apr 2001
Pg. 86-88

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E
, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019
Pg. 428-433

The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E
, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Sep/Oct 2019
Pg. 422-427

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine
DeVeau Ian
Sep/Oct 2007
Pg. 357-362

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Compounding for Veterinary Medicine
Fields Shannon W
Nov/Dec 2006
Pg. 417-418

Veterinary Compounding: A Bird's Eye View
Jordan Dinah G
Jul/Aug 1997
Pg. 222-227

Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
Sep/Oct 2008
Pg. 384-390

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
Mar/Apr 2024
Pg. 136

To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R
, Davidson Gigi S
Sep/Oct 2014
Pg. 366-369

Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 411

Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 233

Dipyrone 500-mg/mL Injection, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 227

Return to Top